Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has…
Royalty Pharma plc (NASDAQ:RPRX) Stocks Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? It is hard to get excited after looking at Royalty Pharmas (NASDAQ:RPRX) recent performance, when its stock has...…
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty Agios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential net sales of a brain…
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions By Investing.com Earnings call: Royalty Pharma reports robust growth and strategic acquisitions…
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it will…
Royalty Pharma Declares Second Quarter 2024 Dividend NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX)…